IVI Drug Pricing Proposal Statement
Jennifer Bright, Executive Director, Innovation and Value Initiative, issued the following statement on Biden Administration and Congressional Democrats drug pricing proposals. “While exercising government levers to address drug pricing and pricing transparency are needed, the current proposals miss the mark on real solutions to improve affordability and to understand whether healthcare spending actually delivers the […]
Supporting Equity in Value Assessment
Author: Rick Chapman, PhD, Chief Science Officer, IVI How do we ensure that the data and methods used for value assessment adequately account for the diversity of patients and the urgent need to correct inequities in the health care system – and society in general? Without explicit attention to these issues, health technology assessment (HTA) […]
What Distinguishes IVI’s Approach to Value Assessment?
Author: Rick Chapman, PhD, Chief Science Officer, IVI Policymakers continue to grapple with finding the right approaches to curtailing drug costs and improving health care. Organizations that conduct value and health technology assessment (HTA) are grappling with finding the right approaches, too. IVI has created a new infographic to illustrate our patient-centered approach to value […]
Toward Equity in Value Assessment: Paths Forward
Author: Jennifer Bright, MPA, Executive Director, IVI “Poor value assessment hardwires inequity into health.” – Michelle McMurry-Heath, MD, PhD; Biotechnology Innovation Organization – Session 1: Meaningful Action Toward Health Equity IVI’s three-part series on health equity and value assessment concluded earlier this month, and we’re proud to have convened these thoughtful dialogues among diverse experts […]
IVI Releases First Annual Report
IVI is pleased to share our Annual Report that documents the transition of our organization to an independent, 501c(3) organization, describes our membership and patient engagement strategies, and offers highlights and learnings from research and convening activities over the past 18 months.
Q&A with IVI’s Executive Director, Jennifer Bright
Jennifer Bright, MPAIVI Executive Director Ms. Bright brings over two decades of health care policy, issue management, patient advocacy, and executive leadership to the role. She is also founder and President of Momentum Health Strategies and has formerly served as executive director of the Society for Healthcare Epidemiology of America, representing physician, advanced practice nurse, […]
Putting Stakeholder Engagement at IVI of Health Economic Modeling for Health Technology Assessment in the United States
IVI economists and staff recently published this open-access article describing specifically how IVI puts stakeholder engagement at the center of value assessment. Read about the engagement process IVI is using to build patient-centricity into its major depressive disorder (MDD) health economic model below or on download a copy from PharmacoEconomics here. Putting Stakeholder Engagement at […]
PRESS RELEASE: Exploring Patient-Driven Value Factors
Value Blueprints Research Brief Explores Patient-Driven Value Element Framework to Identify Factors Most Important to Patients Alexandria, VA — June 3, 2021 — The Innovation and Value Initiative (IVI), an independent, nonprofit research organization dedicated to advancing patient-centric value assessment, today released a research brief describing the application of a patient-driven value elements framework in […]
Questions about the IVI-MDD Model Scope
On Monday, May 3, IVI, along with Jessica Kennedy from Mental Health America and Mohannad Kusti from Pivot Onsite-Innovations, held an informational webinar on the draft model scope for IVIs’s upcoming economic model on major depressive disorder (MDD). To prime the pump for your own comments and feedback, we’re sharing some of the questions and […]
PRESS RELEASE: IVI to Hold Second Methods Summit to Drive Patient-Centered Value Assessment
Summit Will Address Priority Patient Inputs for Comparative Effectiveness Research and HTA Alexandria, VA — April 27, 2021 — The Innovation and Value Initiative (IVI), an independent nonprofit research organization dedicated to advancing patient-centric value assessment, today announced it will convene the second annual Methods Summit, a multi-stakeholder event to drive consensus on priority patient […]